Loading...
Loading...
India's pomalidomide imports from JAPAN total $107.4K across 1 shipments from 1 foreign suppliers. FUJIMOTO PHARMACEUTICAL CORPORATION leads with $107.4K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include DR REDDY S LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for pomalidomide โ a concentrated sourcing relationship with select suppliers from JAPAN.

FUJIMOTO PHARMACEUTICAL CORPORATION is the leading Pomalidomide supplier from JAPAN to India, with import value of $107.4K across 1 shipments. The top 5 suppliers โ FUJIMOTO PHARMACEUTICAL CORPORATION โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | FUJIMOTO PHARMACEUTICAL CORPORATION | $107.4K | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DR REDDY S LABORATORIES LIMITED | $107.4K | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Pomalidomide suppliers from JAPAN to India include FUJIMOTO PHARMACEUTICAL CORPORATION. The leading supplier is FUJIMOTO PHARMACEUTICAL CORPORATION with import value of $107.4K USD across 1 shipments. India imported Pomalidomide worth $107.4K USD from JAPAN in total across 1 shipments.
India imported Pomalidomide worth $107.4K USD from JAPAN across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Pomalidomide sourced from JAPAN include DR REDDY S LABORATORIES LIMITED. The largest buyer is DR REDDY S LABORATORIES LIMITED with $107.4K in imports across 1 shipments.
The total value of Pomalidomide imports from JAPAN to India is $107.4K USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists